ArticleCancer research2025

TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.

Leanne G Ahronian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.